Orphenadrine Citrate Tablet, Extended Release
Product Images NDC 66267-158

2 FDA label images from Nucare Pharmaceuticals, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Orphenadrine Citrate (NDC 66267-158). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nucare Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

S:\ra\2011 Anda\orphenadrine Citrate Er Tablets\cbe (Labeling\Backup\062812\figure-01.jpg)

S:\ra\2011 Anda\orphenadrine Citrate Er Tablets\cbe (Labeling\Backup\062812\figure-01.jpg)
Chemical structure of Orphenadrine Citrate showing its molecular components as depicted in the image.*
FDA Label Image

66267 158 20

66267 158 20
Orphenadrine Citrate 100 mg extended-release oral tablets, supplied in a package of 20 tablets. The label shows the product NDC 66267-158-20 and notes debossed "NL4" on one side of the round white/off-white tablets. Manufactured by Novel Laboratories, Inc. and packaged by NuCare Pharmaceuticals, Inc., Orange, CA. The label includes storage instructions and caution to keep out of reach of children.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.